Viewing Study NCT00439192

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:58 PM

Ignite Modification Date: 2025-12-27 @ 11:55 AM

Study NCT ID: NCT00439192

Status: TERMINATED

Last Update Posted: 2007-08-08

First Post: 2007-02-22

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)

Sponsor: elbion AG

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module